MAKALUVAMINE-P
Compound with spectra: 2 NMR
| SpectraBase Compound ID | DtE96JE2P37 |
|---|---|
| InChI | InChI=1S/C20H21N3O2/c1-22-10-8-14-12-23(2)19-18(14)17(22)11-16(20(19)25)21-9-7-13-3-5-15(24)6-4-13/h3-6,11-12,24H,7-10H2,1-2H3/p+1 |
| InChIKey | OLEMIURMTKKFSE-UHFFFAOYSA-O |
| Mol Weight | 336.42 g/mol |
| Molecular Formula | C20H22N3O2 |
| Exact Mass | 336.171202 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1H-pyrrole-3-carboxylic acid, 4-[[1-(2,6-dimethylphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-1-(2-furanylmethyl)-4,5-dihydro-2-methyl-5-oxo-, methyl ester, (4Z)-
Methyl 6-Methyl-7-tert-butoxy-4-acetoxy-9-hydroxy-3-oxobicyclo[4.3.0]non-1-en-2-carboxylate isomer
Acenaphtheno[1,2-l]-4,5-dihydropyrene
5-(4-Acetyl-3-ethyl-2-oxobicyclo[3.3.0]oct-3-en-8-yl)-4-acetyl-3-ethyl-2(3H)-furanone
DIHYDROCHELONANTHOSIDE-TETRAACETATE
2H,8H-pyrano[2,3-f][1,3]benzoxazine-3-acetic acid, 6-chloro-9,10-dihydro-4-methyl-2-oxo-9-(1-phenylethyl)-, methyl ester
2-(benzylsulfanyl)-3-isobutyl-6,6-dimethyl-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
10-[3'.5'-(bisTrifluoromethyl)phenyl]-3-(methoxycarbonyl)isoalloxazine
(4AR, 7S,9R,10R,11aS)-10-bromo-octahydro-4a,9-epoxy-7,11a-methano-5H-benzocyclononene-3,12(4H)-dione
5-(2-methoxyphenyl)-2-(2-thienyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
| Title | Journal or Book | Year |
|---|---|---|
| Makaluvamine P, a New Cytotoxic Pyrroloiminoquinone from Zyzzya cf. fuliginosa | Journal of Natural Products | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.